INREBIC vs OPZELURA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Possible drug interaction. INREBIC and OPZELURA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	INREBIC	OPZELURA
Rating	New	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	FEDRATINIB HYDROCHLORIDE	RUXOLITINIB PHOSPHATE
Manufacturer	Bristol-Myers	Incyte Corp
Dosage forms	Capsule	Topical
Drug class	—	Janus Kinase Inhibitor
Boxed warning	None	Boxed warning
Treats	Primary Myelofibrosis	Polycythemia Vera, Primary Myelofibrosis

inrebic opzelura

Rating

New

Pharmacy pays

—

Type

Active ingredient

FEDRATINIB HYDROCHLORIDE

RUXOLITINIB PHOSPHATE

Manufacturer

Bristol-Myers

Incyte Corp

Dosage forms

Capsule

Topical

Drug class

—

Janus Kinase Inhibitor

Boxed warning

None

Boxed warning

Treats

Primary Myelofibrosis

Polycythemia Vera, Primary Myelofibrosis

Frequently asked questions

What is the difference between Inrebic and Opzelura?

Inrebic contains Fedratinib Hydrochloride, while Opzelura contains Ruxolitinib Phosphate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.